StockpollyBeta
Get App
Popularity #316
ILMN · NASDAQ · Medical - Diagnostics & Research

Illumina (ILMN)

Supplies sequencing and array instruments, recurring consumables, informatics, and multiomics workflows.

$251.12
vs last close+3.66 (+1.48%)

In millions of USD, except per-share figures

In millionsQ3 FY23Oct 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue1,1191,1221,0761,1121,0801,1041,0411,0571,0831,1601,0911,159
Cost of revenue435448409391335376356340351382370389
Gross profit684674667721745728685717732778721770
1,4388387782,3584526501495501521512525
Research & development315341338325253255241243228238240252
303485439147239271260252273283272273
General & administrative00000000000273
Other expenses8201211,886−4880000000
Operating income−754−164−111−1,637741202184222231257209245
−28−32−339−21−14−284−11121−5215
Interest income1311121311101110910110
Interest expense19181820362525252526240
Other non-operating income9−15−20319−15−11−23−109−14−14728−15
Income before tax−782−167−109−1,976720188182306220378157260
Income tax expense−2881712151517170442353
Net income from continuing operations−754−175−126−1,988705187131235150334134207
Net income−754−175−126−1,988705187131235150334134207
EPS, basic−$4.77−$1.11−$0.79−$12.50$4.43$1.18$0.82$1.50$0.98$2.18$0.88$1.37
EPS, diluted−$4.77−$1.11−$0.79−$12.50$4.41$1.17$0.82$1.50$0.97$2.17$0.87$1.35
Weighted average shares, basic158159159159159159159157153153153151
Weighted average shares, diluted158159159159160160159157154154154153
EBITDA−655−4017−1,851826283276399312471250330
Depreciation & amortization1081091081057071696867676970
EBIT−763−149−91−1,956756212207331245404181260